![]() |
|
|
Vol. 286, Issue 1, 61-69, July 1998
Department of Psychiatry and Human Behavior (J.K.R, K.M.W, W.L.W.),
Department of Pharmacology and Toxicology (K.M.W., W.L.W.), University
of Mississippi Medical Center, Jackson, Mississippi
Low, nonreinforcing doses of heroin have been shown to shift the
dose-response function of cocaine leftward in rhesus monkeys trained
under a progressive-ratio schedule of i.v. drug injection. Our study
sought to determine 1) whether a reciprocal enhancement of heroin
self-administration would be observed when heroin was combined with
low, nonreinforcing doses of cocaine, and 2) whether self-administration of cocaine-heroin combinations could be antagonized by the opioid antagonist naltrexone. Rhesus monkeys
(n = 4) were prepared with i.v. catheters and
trained to self-administer cocaine under a progressive-ratio schedule.
The initial response requirement of this schedule was fixed-ratio 120, which doubled across the session to a maximum of 1920. Injections were
separated by a 30-min time out. Cocaine dose-response functions
(6.4-100 µg/kg/injection) for injections/session and breakpoints
were monophasic, i.e., increased with dose until
responding reached a maximum. Heroin dose-response functions (1.6-25
µg/kg/injection) either increased to a peak and then decreased or
reached an asymptote. When nonreinforcing doses of cocaine (3.2-25
µg/kg/injection) were combined with heroin, the heroin dose-response
function was shifted to the left, without change in maximum
injections/session. Presession treatments with naltrexone (3.2-1600
µg/kg, i.m., 10-min presession) antagonized self-administration of
heroin and heroin + cocaine combinations in a dose-dependent fashion.
However, naltrexone treatment had no effect on cocaine
self-administration. Antagonism by naltrexone of self-administration of
heroin and heroin + cocaine was surmounted by increasing the dose of
heroin either alone or in the heroin + cocaine combination. In
vivo apparent pA2 and pKB analyses of these data revealed values of approximately 8.0, consistent with a role
for mu opioid receptors in the self-administration of
heroin and cocaineheroin (i.e., "speedball")
combinations.
This article has been cited by other articles:
![]() |
J. K. Rowlett, D. M. Platt, W.-D. Yao, and R. D. Spealman Modulation of Heroin and Cocaine Self-Administration by Dopamine D1- and D2-Like Receptor Agonists in Rhesus Monkeys J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1135 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Winger, C. M. Galuska, S. R. Hursh, and J. H. Woods Relative Reinforcing Effects of Cocaine, Remifentanil, and Their Combination in Rhesus Monkeys J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 223 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Rowlett, J. S. Rodefer, and R. D. Spealman Self-Administration of Cocaine-Opioid Combinations by Rhesus Monkeys: Evaluation of the Role of {micro} Receptor Efficacy Using Labor Supply Analysis J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1289 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bowen, B. D. Fischer, N. K. Mello, and S. S. Negus Antagonism of the Antinociceptive and Discriminative Stimulus Effects of Heroin and Morphine by 3-Methoxynaltrexone and Naltrexone in Rhesus Monkeys J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 264 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bidlack, D. J. Cohen, J. P. McLaughlin, R. Lou, Y. Ye, and M. P. Wentland 8-Carboxamidocyclazocine: A Long-Acting, Novel Benzomorphan J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 374 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Platt, J. K. Rowlett, and R. D. Spealman Discriminative Stimulus Effects of Intravenous Heroin and Its Metabolites in Rhesus Monkeys: Opioid and Dopaminergic Mechanisms J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 760 - 767. [Abstract] [Full Text] [PDF] |
||||